Bausch & Lomb (BLCO) Return on Capital Employed (2022 - 2026)
Bausch & Lomb's (BLCO) quarterly Return on Capital Employed came in at 2.71% in Q2 2026, up 240.0% YoY from 0.8% in Q2 2025, and up 42.84% on a QoQ basis from 1.9% in Q1 2026.
Bausch & Lomb (BLCO) Return on Capital Employed (2022 - 2026) Analysis & Trends
Bausch & Lomb (BLCO) has 5 years of Return on Capital Employed data on file, last reported at 2.71% in Q2 2026.
- Quarterly Return on Capital Employed rose 240.0% year-over-year to 2.71% in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 2.71% (up 240.0% YoY) and the FY2025 annual result came in at 0.96%, down 43.0% from the prior year.
- Return on Capital Employed advanced to 2.71% in Q2 2026, from 1.9% in the prior quarter.
- In the past five years, Return on Capital Employed ranged from a high of 3.06% in Q2 2022 to a low of 0.31% in Q2 2025.
- A 5-year average of 1.55% and a median of 1.3% in 2023 frame the typical range for Return on Capital Employed.
- Annual changes were most pronounced in 2023 — Return on Capital Employed sank 167 bps — and 2026, when it jumped 240 bps.
- Tracing BLCO's Return on Capital Employed over 5 years: stood at 2.15% in 2022, then plunged by 48 bps to 1.11% in 2023, then gained by 24 bps to 1.38% in 2024, then plunged by 32 bps to 0.94% in 2025, then jumped by 188 bps to 2.71% in 2026.
- The last three Return on Capital Employed figures came in at 2.71% (Q2 2026), 1.9% (Q1 2026), and 0.94% (Q4 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 18.58% |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 6.00% |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 28.11% |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 25.22% |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 5.57% |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 19.71% |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 19.76% |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 4.68% |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 3.28% |
| 10 | Bausch & Lomb | 6.14 Bn | 5.76 Bn | 867.00 Mn | 2.71% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.71% |
| Mar 31, 2026 | 1.90% |
| Dec 31, 2025 | 0.94% |
| Sep 30, 2025 | 0.74% |
| Jun 30, 2025 | 0.31% |
| Mar 31, 2025 | 0.62% |
| Dec 31, 2024 | 1.38% |
| Sep 30, 2024 | 1.07% |
| Jun 30, 2024 | 1.04% |
| Mar 31, 2024 | 1.17% |
| Dec 31, 2023 | 1.11% |
| Sep 30, 2023 | 1.22% |
| Jun 30, 2023 | 1.39% |
| Mar 31, 2023 | 1.52% |
| Dec 31, 2022 | 2.15% |
| Sep 30, 2022 | 2.57% |
| Jun 30, 2022 | 3.06% |
| Mar 31, 2022 | 3.05% |